Oncostatin M: a pleiotropic cytokine in the central nervous system

被引:75
作者
Chen, SH
Benveniste, EN
机构
[1] Univ Alabama Birmingham, Dept Cell Biol, MCLM 386, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Cell Biol, MCLM 395, Birmingham, AL 35294 USA
关键词
oncostatin M; signal transduction; central nervous system; brain tumors; glial cells;
D O I
10.1016/j.cytogfr.2004.06.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oncostatin M (OSM), a member of the interleukin-6 (IL-6) cytokine family, has yet to be well studied, especially in the context of the central nervous system (CNS). The biological functions of OSM are complex and variable, depending on the cellular microenvironment. Inflammatory responses and tumor development are among two of the major events that OSM is involved in. Although OSM levels remain low in the normal CNS. elevated expression occurs in pathological conditions. Therefore, it is crucial to understand the regulation of OSM to control its expression and/or its effects. Accumulating data demonstrate that OSM binds to specific receptor complexes, then activates two major signaling pathways: Janus Kinase-Signal Transducers and Activators of Transcription (JAK-STAT) and Mitogen-Activated Protein Kinase (MAPK), to regulate downstream events. In this review, we focus on the biological functions of OSM, the signaling pathways of OSM in the CNS. and OSM involvement in CNS diseases. (C) 2004, Elsevier Ltd. All rights reserved.
引用
收藏
页码:379 / 391
页数:13
相关论文
共 120 条
  • [11] Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines
    Bugno, M
    Witek, B
    Bereta, J
    Bereta, M
    Edwards, DR
    Kordula, T
    [J]. FEBS LETTERS, 1999, 448 (01): : 9 - 14
  • [12] LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival
    Butzkueven, H
    Zhang, JG
    Hanninen, MS
    Hochrein, H
    Chionh, F
    Shipham, KA
    Emery, B
    Turnley, AM
    Petratos, S
    Ernst, M
    Bartlett, PF
    Kilpatrick, TJ
    [J]. NATURE MEDICINE, 2002, 8 (06) : 613 - 619
  • [13] Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas
    Chaudhry, IH
    O'Donovan, DG
    Brenchley, PEC
    Reid, H
    Roberts, ISD
    [J]. HISTOPATHOLOGY, 2001, 39 (04) : 409 - 415
  • [14] Specific inhibition of Stat3 signal transduction by PIAS3
    Chung, CD
    Liao, JY
    Liu, B
    Rao, XP
    Jay, P
    Berta, P
    Shuai, K
    [J]. SCIENCE, 1997, 278 (5344) : 1803 - 1805
  • [15] STATs and gene regulation
    Darnell, JE
    [J]. SCIENCE, 1997, 277 (5332) : 1630 - 1635
  • [16] Oncostatin M in the normal human testis and several testicular disorders
    De Miguel, MP
    Regadera, J
    Martinez-Garcia, F
    Nistal, M
    Paniagua, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) : 768 - 774
  • [17] The DNA sequence of human chromosome 22
    Dunham, I
    Shimizu, N
    Roe, BA
    Chissoe, S
    Dunham, I
    Hunt, AR
    Collins, JE
    Bruskiewich, R
    Beare, DM
    Clamp, M
    Smink, LJ
    Ainscough, R
    Almeida, JP
    Babbage, A
    Bagguley, C
    Balley, J
    Barlow, K
    Bates, KN
    Beasley, O
    Bird, CP
    Blakey, S
    Bridgeman, AM
    Buck, D
    Burgess, J
    Burrill, WD
    Burton, J
    Carder, C
    Carter, NP
    Chen, Y
    Clark, G
    Clegg, SM
    Cobley, V
    Cole, CG
    Collier, RE
    Connor, RE
    Conroy, D
    Corby, N
    Coville, GJ
    Cox, AV
    Davis, J
    Dawson, E
    Dhami, PD
    Dockree, C
    Dodsworth, SJ
    Durbin, RM
    Ellington, A
    Evans, KL
    Fey, JM
    Fleming, K
    French, L
    [J]. NATURE, 1999, 402 (6761) : 489 - 495
  • [18] Pharmacological inhibitors of MAPK pathways
    English, JM
    Cobb, MH
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (01) : 40 - 45
  • [19] Ensoli F, 1999, J IMMUNOL, V162, P6268
  • [20] Lymphomononuclear cells from multiple sclerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors α and β, and interferon γ
    Ensoli, F
    Fiorelli, V
    Lugaresi, A
    Farina, D
    De Cristofaro, M
    Collacchi, B
    Muratori, DS
    Scala, E
    Di Gioacchino, M
    Paganelli, R
    Aiuti, F
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (04) : 284 - 288